Cyramza

Medicinal product

(Invented) name

Cyramza

Active substance (s)

Ramucirumabas

Strength

10 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FG02, Ramucirumab

Marketing authorisation holder

Eli Lilly Nederland B.V., Nyderlandai

Date of authorisation

2014-12-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Ramucirumabas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61061	75373	1075373	flakonas	10 ml N1		Receptinis	EU/1/14/957/001	Tiekiama	-	-	No	-	-
61062	75374	1075374	flakonas	10 ml N2		Receptinis	EU/1/14/957/002	Netiekiama	-	-	No	-	-
61063	75375	1075375	flakonas	50 ml N1		Receptinis	EU/1/14/957/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-12-19	Registruotas